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BACKGROUND 
CONCLUSIONS 
Background 
Anaemia affects 60-90% of people with cancer. A lower 
haemoglobin (Hb) is associated with a worse quality of life. 
Erythropoietin treatment improves both Hb and quality of 
life but is associated with significant risk. Blood transfusions 
improve Hb but only have a short-term effect on quality of 
life.  
Stored blood has a reduced NO bioavailability causing 
reduced vasodilation, reduced blood flow and oxygen 
delivery to muscles, and reduced exercise tolerance and 
muscle oxidative function. 
Dietary nitrate supplementation has been shown to be of 
significant benefit in healthy individuals. It improves 
mitochondrial efficiency, reduces metabolic rate, increases 
blood flow to areas of the body requiring more oxygen, and 
reduces the effect of hypoxia on exercise capacity and 
muscle recovery. 
Therefore, we hypothesise that dietary supplementation of 
anaemic patients with nitrate-rich beetroot juice (BR) will 
have similar beneficial effects, compared to nitrate-deplete 
beetroot juice (PL). 
Hypotheses 
1. Dietary supplementation with Nitrate ameliorates the 
symptoms of chronic anaemia 
2. Blood transfusions contain more nitrate scavengers than 
circulating blood, meaning patients receiving blood 
transfusions have an altered nitrate metabolism 
3. Nitrate supplementation improves the following in 
anaemic patients: 
1. Cognitive function 
2. Muscular function and exercise tolerance 
3. Quality of life 
4. Thrombogenicity 
Aims 
1. This pilot randomised control study is examining the 
feasibility of the recruitment of patients with cancer-
related anaemia 
2. Provide estimates of standard deviations in main 
outcome measures 
3. Guide power calculations for a future study 
investigating whether nitrate supplementation is 
beneficial for anaemic patients 
Objectives 
Objectives include analysis of ease of recruitment and study 
completion rates, estimation of standard deviations of main 
outcomes, quality of life data collection, analysis of exercise 
tolerance and related measures, refinement of 
measurements of S-Nitrosothiols, nitrate, and analysis of 
platelet aggregation. 
This prospective randomised crossover study is recruiting patients with 
anaemia who attend the Royal Devon and Exeter Haematology and 
Oncology Departments. Participants attend The University of Exeter 4 
times for quality of life assessment, blood pressure measurement, 
exercise physiology and Magnetic Resonance Spectroscopy (MRS) 
analysis.  
They receive both BR and PL supplementation during their trial 
involvement as outlined below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RECRUITMENT 
• 33 patients recruited so far (target 40) 
• 4 withdrawals (2 due to patient ill health, 1 due to ill health of wife, 
one because of refusal by another trial) 
• 21 patients have completed all 4 visits 
PATIENT DEMOGRAPHICS 
• Age range 43 to 93 (mean 68) 
• Mean Hb 110.9 g/l 
• 19 males, 14 females 
DATA 
Interim analysis of data will occur shortly when researchers are 
unblinded following completion of 1 more patient’s visits. No further 
results regarding the hypotheses are available at present. 
RESULTS 
METHODS 
This study is recruiting well and is easily meeting its targets. Most 
patients approached are keen to enrol.  Interim analysis is about to 
commence. 
